Roger M Vilardaga
Assistant Professor in Psychiatry and Behavioral Sciences

Roger Vilardaga, Ph.D. is an Assistant Professor at the Department of Psychiatry and Behavioral Sciences at Duke University. He is also Affiliate Professor a the Department of Human Centered Design and Engineering at the University of Washington. Roger studied psychology at the Universitat de Barcelona and received his doctoral degree in clinical psychology from the University of Nevada, Reno. In 2014 he received a 5-Year Pathway to Independence Award from the National Institute on Drug Abuse. This Award provided training in user-centered design and funded the first NIH-funded smartphone app to deliver smoking cessation treatment for individuals with serious mental illness. From 2010 to 2015 he served as Associate Editor of the Journal of Contextual Behavioral Science.

Roger is passionate about the potential of digital technologies for the advancement of behavioral science, and the development of cost-effective and higher-reaching behavioral interventions. He directs the 'Access to Behavioral Health for All' (ABHA) lab, at Duke's Center for Addition Science and Technology. The focus of the ABHA lab is to ideate, develop, and test digital behavioral health interventions for underserved populations, such as individuals who experience persistent mental health symptoms, addiction, or chronic pain. It specializes in: (1) designing digital tools to foster behavioral health and psychological resilience, and (2) the application of rigorous strategies to evaluate them. Using a multi-method approach that includes the use of user-centered design research, small-n experimental designs, and clinical trials methodology, the lab combines data from qualitative interviews, app background analytics, clinical interviews, and self-reports to better understand the behavior of digital health users.

Roger has served as ad-hoc reviewer for more than 25 scientific journals and 4 granting institutions (including the US's Center for Scientific Review), and has received grant funding from the National Institute on Drug Abuse, the University of Washington Innovation Award, Pfizer, the National Cancer Institute, and Duke University.

Current Appointments & Affiliations

Contact Information

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.